Drug enrichment and discovery from schizophrenia genome-wide association results: an analysis and visualisation approach
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug enrichment and discovery from schizophrenia genome-wide association results: an analysis and visualisation approach
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-09-25
DOI
10.1038/s41598-017-12325-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The druggable genome and support for target identification and validation in drug development
- (2017) Chris Finan et al. Science Translational Medicine
- Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia
- (2016) Simone de Jong et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Chromosome conformation elucidates regulatory relationships in developing human brain
- (2016) Hyejung Won et al. NATURE
- Translating genome-wide association findings into new therapeutics for psychiatry
- (2016) Gerome Breen et al. NATURE NEUROSCIENCE
- Open Targets: a platform for therapeutic target identification and validation
- (2016) Gautier Koscielny et al. NUCLEIC ACIDS RESEARCH
- GTM-Based QSAR Models and Their Applicability Domains
- (2015) H. A. Gaspar et al. Molecular Informatics
- Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic
- (2015) T Lencz et al. MOLECULAR PSYCHIATRY
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- The support of human genetic evidence for approved drug indications
- (2015) Matthew R Nelson et al. NATURE GENETICS
- LD Score regression distinguishes confounding from polygenicity in genome-wide association studies
- (2015) Brendan K Bulik-Sullivan et al. NATURE GENETICS
- DGIdb 2.0: mining clinically relevant drug–gene interactions
- (2015) Alex H. Wagner et al. NUCLEIC ACIDS RESEARCH
- Ensembl 2016
- (2015) Andrew Yates et al. NUCLEIC ACIDS RESEARCH
- MAGMA: Generalized Gene-Set Analysis of GWAS Data
- (2015) Christiaan A. de Leeuw et al. PLoS Computational Biology
- The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function
- (2014) Stefan M. Berger et al. CELL AND TISSUE RESEARCH
- Maintenance Treatment With Varenicline for Smoking Cessation in Patients With Schizophrenia and Bipolar Disorder
- (2014) A. Eden Evins et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genenames.org: the HGNC resources in 2015
- (2014) Kristian A. Gray et al. NUCLEIC ACIDS RESEARCH
- STRING v10: protein–protein interaction networks, integrated over the tree of life
- (2014) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease
- (2013) Karen L. Teff et al. DIABETES
- Rational drug repositioning by medical genetics
- (2013) Zhong-Yi Wang et al. NATURE BIOTECHNOLOGY
- Genome-wide association analysis identifies 13 new risk loci for schizophrenia
- (2013) Stephan Ripke et al. NATURE GENETICS
- Major channels involved in neuropsychiatric disorders and therapeutic perspectives
- (2013) Paola Imbrici et al. Frontiers in Genetics
- Five Years of GWAS Discovery
- (2012) Peter M. Visscher et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Use of genome-wide association studies for drug repositioning
- (2012) Philippe Sanseau et al. NATURE BIOTECHNOLOGY
- Mining for Bioactive Scaffolds with Scaffold Networks: Improved Compound Set Enrichment from Primary Screening Data
- (2011) Thibault Varin et al. Journal of Chemical Information and Modeling
- Genome-wide association study identifies five new schizophrenia loci
- (2011) NATURE GENETICS
- Deficits in GABAB receptor system in schizophrenia and mood disorders: A postmortem study
- (2011) S. Hossein Fatemi et al. SCHIZOPHRENIA RESEARCH
- Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study
- (2009) Paul Lichtenstein et al. LANCET
- Role of genetic variants in the CHRNA5–CHRNA3–CHRNB4 cluster in nicotine dependence risk: importance of gene–environment interplay
- (2009) L Greenbaum et al. MOLECULAR PSYCHIATRY
- Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia
- (2007) Robert W. Buchanan et al. AMERICAN JOURNAL OF PSYCHIATRY
- Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin
- (2007) Tony Taldone et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started